Clinical Trials
137 trialsTissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
National Institutes of Health Clinical Center (CC)
DESCENT-1
A2 Biotherapeutics Inc.
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
DOTATOC PET/CT for Imaging NET Patients
British Columbia Cancer Agency
NYULCBC
NYU Langone Health
Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment
Shanghai Chest Hospital
DP-04
AstraZeneca
LUNGEVITY
Groupe Francais De Pneumo-Cancerologie
COMETH
University of Kansas Medical Center
Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
Medical University of Bialystok
IKF-ReWoLuTe
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
Tempus AI
SCLC Tarlatamab Blood Collection
Duke University
SCLC
Jazz Pharmaceuticals
A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
ARSENAL
AstraZeneca
PHILUCA
Zealand University Hospital
Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)
Peking University Cancer Hospital & Institute
IMreal
Hoffmann-La Roche
CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer
Shandong Cancer Hospital and Institute
7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)
University of Missouri-Columbia
ES-SCLC
Henan Cancer Hospital
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Dana-Farber Cancer Institute
PROPHETIC
OncoHost Ltd.
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
University of Colorado, Denver
A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
Tianjin First Central Hospital
Prospective Observational Study on ES-SCLC
Peking Union Medical College Hospital
SUCCEED
Addario Lung Cancer Medical Institute
A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)
Addario Lung Cancer Medical Institute
Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
Indiana University
Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer
Shanghai Chest Hospital of Shanghai Jiao Tong University
ARAL
AstraZeneca
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases
Azienda USL Reggio Emilia - IRCCS
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
University College, London
SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
Fuzhou General Hospital
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
STRATUS
Oncology Center of Biochemical Education And Research
A Multicenter Cancer Biospecimen Collection Study
Cofactor Genomics, Inc.
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
Peking University Cancer Hospital & Institute
Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer
Hunan Cancer Hospital
CRISP
AIO-Studien-gGmbH
SCLC-OMICS
Aalborg University Hospital
A Study on the Efficacy of Atezolizumab Combined with Chemotherapy
Shanghai Pulmonary Hospital, Shanghai, China
EDUR-BRA
AstraZeneca
Cognitive Screening in Lung Cancer Patients
European Institute of Oncology
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
Massachusetts General Hospital
Molecular Analysis and Treatment Options of SCLC
Shanghai Chest Hospital
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
CLINATEZO
Intergroupe Francophone de Cancerologie Thoracique